Pfizer’s Revatio flunks paediatric hypertension studyAn attempt by Pfizer to extend the uses of its pulmonary artery hypertension (PAH) drug Revatio into a Share XPfizer’s Revatio flunks paediatric hypertension studyhttps://pharmaphorum.com/news/pfizers-revatio-flunks-paediatric-hypertension-study/
Owlstone signs deal with J&J’s Actelion for PH breath testUK-based Owlstone Medical has signed a deal with Johnson & Johnson’s Actelion unit, to discover and validate a Share XOwlstone signs deal with J&J’s Actelion for PH breath testhttps://pharmaphorum.com/news/owlstone-signs-deal-with-jjs-actelion-for-ph-breath-test/
